Figure 1: A graph of the Case I patient’s autism spectrum quotation test scores
FIGURE 1
Parameter |
Group 1 |
Group 2 |
Group 3 |
P |
Test of significance |
Mean age (years) ± SD |
29.80 ± 3.77 |
30.54 ± 3.85 |
30.32 ± 4.10 |
0.347 |
F= 1.061 |
Mean BMI (Kg/m2) ± SD |
27.97 ± 2.94 |
27.84 ± 2.96 |
27.23 ± 2.52 |
0.092 |
F= 2.401 |
Median & IQR of duration of infertility (years) |
5.50(3.0–8.0) |
5.0(2.70–8.0) |
4.0(3.0 – 6.90) |
0.114 |
H= 4.351 |
Median & IQR of AMH level (ng/dl) |
2.36(1.78–2.95) |
2.25(1.62–2.68) |
1.98(1.40–2.95) |
0.052 |
H= 5.928 |
Mean antral follicular count (AFC) ± SD |
15.87 ± 3.73 |
15.53 ± 3.35 |
15.54 ± 4.25 |
0.751 |
F= 0.287 |
Median (IQR) of Total FSH dose (IU) |
1600(1500–2000) |
1650(1500–2000) |
1800(1500–2100) |
0.388 |
H= 1.892 |
Median & IQR of follicles (≥11 mm) on day of trigger |
15.50(12.0–20.0) |
15.0(12.0–20.0) |
15.0(11.0–20.0) |
0.6 |
H= 1.023 |
Median & IQR of peak estradiol on day of trigger (pg/ mL) |
3967.5(2541.5–5754) |
3166.5(2174.5–4384) |
2408(1437.5 –3638.5) |
<0.001* |
H= 34.891* |
Median & IQR of peak progesterone on day of trigger (ng/ mL) |
0.88(0.59–1.20) |
1.01(0.58–1.36) |
0.89(0.54–1.28) |
0.34 |
H= 2.160 |
Table 1: Baseline characteristics and ovarian stimulation details of the study groups
F: F for ANOVA test H: H for Kruskal Wallis test
p: p value for comparing between the three studied groups
*: Statistically significant at p ≤ 0.05
Parameter |
Group 1 |
Group 2 |
Group 3 |
p |
Test of significance |
Median (IQR) oocytes retrieved |
15.0 (10.0–22.0) |
14.0 (10.0–19.0) |
14.0 (9.0–18.0) |
0.047* |
H = 6.117* |
Median ORR (%) |
92.86 |
90 |
87.5 |
< 0.001* |
H = 15.342* |
Mean ± SD MII oocytes percentage |
71.75 ± 16.30 |
76.72 ± 19.32 |
81.27 ± 16.50 |
< 0.001* |
F = 8.911* |
Median (IQR) MI oocytes percentage |
14.64(6.90 – 22.65) |
10.0(0.0–20.0) |
10.0 (0.0 – 17.71) |
0.031* |
H = 6.924* |
Median (IQR) GV oocytes percentage |
10.53(4.77–20.0) |
7.14(0.0–15.38) |
0.0(0.0–9.09) |
< 0.001* |
H =40.588* |
Table 2: Fertilization, implantation & blastocyst rates in the three study groups
F: F for ANOVA test H: H for Kruskal Wallis test
p: p value for comparing between the three studied groups
*: Statistically significant at p ≤ 0.05
Parameter |
Group 1 |
Group 2 |
Group 3 |
P |
Test of significance |
Median (IQR) fertilization rate (%) |
73.50(61.0–85.0) |
77.35(66.50–90.0) |
75.0(63.0–90.0) |
0.48 |
H= 1.466 |
Median (IQR) implantation rate (%) |
50.0(0.0–50.0) |
25.0(0.0–50.0) |
50.0(0.0–50.0) |
0.203 |
H= 3.192 |
Median (IQR) blastocyst rate (%) |
50.0(33.33–66.67) |
66.7(33.33–66.67) |
50.0(26.79–100.0) |
0.346 |
H= 2.124 |
Median (IQR) number of grade A embryos |
1.0(0.0–2.0) |
1.0(0.0–2.0) |
1.0(0.0–2.0) |
0.85 |
H= 0.325 |
Table 3: Fertilization, implantation & blastocyst rates in the three study groups
H: H for Kruskal Wallis test
p: p value for comparing between the three studied groups
OHSS |
Group 1 No. |
Group 2 |
Group 3 |
λ2 |
p |
|||
No. |
% |
No. |
% |
No. |
% |
|||
No OHSS |
97 |
86.6 |
102 |
91.1 |
115 |
90.6 |
2.987 |
0.56 |
Mild OHSS |
13 |
11.6 |
9 |
8 |
12 |
9.4 |
||
Moderate OHSS |
2 |
1.8 |
1 |
0.9 |
0 |
0 |
||
Table 4: Comparison between the three studied groups according to OHSS
λ2: Chi square test
p: p value for comparing between the three studied groups
Figure 1: A graph of the Case I patient’s autism spectrum quotation test scores
Figure 2: A graph of the Case II patient’s autism spectrum quotation test scores
Figures at a glance